All In Biotech

Drug Trial Radar · NCT05516992

Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine

A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease

Last checked: Nov 19, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 417 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

417

Actual

Start

Aug 19, 2022

Primary completion

Mar 21, 2025

Study completion Aug 27, 2025

Sponsor

Lead sponsor
Spine BioPharma, IncIndustry
Sponsor type
Industry
Collaborators
MCRA
First posted
Aug 26, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related disability due to Lumbar Degenerative Disc Disease. The primary effectiveness hypothesis is superiority of the investigational product relative to control in terms of the percentage of subjects improving in pain-related disability.

Conditions

  • Lumbar Degenerative Disc Disease

Interventions

  • SB-01 For InjectionDrug

    Intradiscal injection

  • Sham NeedleDrug

    Sham needle placement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in function on the Oswestry Disability Index (ODI) at 6 months.Time frame: Baseline/Screening and 6 Month

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Central Alabama Research

    Birmingham, Alabama

  • Evolve Clinical Research

    Phoenix, Arizona

  • Neurovations Research

    Napa, California

  • Source Healthcare

    Santa Monica, California

  • Science Connections, LLC

    Doral, Florida

  • Coastal Clinical Research

    Jacksonville, Florida

  • Conquest Research

    Orlando, Florida

  • Conquest Research

    Orlando, Florida

  • Pain Relief Centers

    St. Petersburg, Florida

  • Tampa Pain Relief Center

    Tampa, Florida

  • Florida Pain Relief Group

    Tampa, Florida

  • Conquest Research

    Winter Park, Florida

  • Vista Clinical Research, LLC

    Newnan, Georgia

  • Injury Care Research

    Boise, Idaho

  • The Orthopaedic Research Foundation, Inc (OrthoIndy)

    Indianapolis, Indiana

  • Abay Neuroscience Center

    Wichita, Kansas

  • OrthoNebraska

    Omaha, Nebraska

  • Pioneer Clinical Research

    New York, New York

  • Meta Medical Research Institute

    Cincinnati, Ohio

  • META Medical Research Institute

    Dayton, Ohio

  • The Orthopedic Center

    Tulsa, Oklahoma

  • HD Research

    Bellaire, Texas

  • NeuroCare Partners

    Houston, Texas

  • South Texas Spinal Clinic

    San Antonio, Texas

  • Precision Spine Care

    Tyler, Texas

  • Tranquil Clinical Research

    Webster, Texas

  • Wasatch Clinical Research

    Salt Lake City, Utah

  • University of Utah

    Salt Lake City, Utah

  • Virginia iSpine Physicians

    Richmond, Virginia

  • Gershon Pain Specialists

    Virginia Beach, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.